You're talking about an entirely new-ish market with using PRO 140 for treatment-naive HIV patients during the 2 weeks while they receive their genotype lab work back. I, too, am very surprised this hasn't gained more attention because you're talking about further increasing the market for PRO 140. Very excited to see when they submit their protocol for this use and what the FDAs response is.